Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells

H P Reusch1, S Zimmermann, M Schaefer

  • 1Institut für Klinische Pharmakologie und Toxikologie, Freie Universität Berlin, Garystr. 5, 14195 Berlin, Germany. reusch@medizin.fu-berlin.de

Insights

Platelet-derived growth factor (PDGF) and thrombin differentially regulate vascular smooth muscle cell (VSM) phenotype. The balance between PI 3-kinase/Akt and Ras/Raf/MEK pathways dictates ERK1/2 phosphorylation and VSM cell differentiation.

Area of Science:

  • Vascular Biology
  • Cell Signaling
  • Molecular Medicine

Background:

  • Vascular smooth muscle (VSM) cells undergo phenotypic modulation in response to growth factors and signaling molecules.
  • Platelet-derived growth factor (PDGF) is a known mitogen for VSM cells, while thrombin also activates similar signaling pathways.
  • Understanding the differential effects of these stimuli on VSM cell phenotype is crucial for cardiovascular research.

Purpose of the Study:

  • To investigate the distinct signaling mechanisms by which PDGF and thrombin influence VSM cell phenotype.
  • To elucidate the role of the Ras/Raf/MEK/ERK and PI 3-kinase/Akt pathways in mediating these cellular responses.
  • To determine how the interplay between these pathways regulates VSM cell differentiation markers like SM-MHC.

Main Methods:

  • Stimulation of VSM cells with PDGF and thrombin.
  • Analysis of signaling pathway activation, including ERK1/2 and Akt phosphorylation.
  • Measurement of smooth muscle-specific myosin heavy chain (SM-MHC) promoter activity.
  • Use of dominant-negative Akt and constitutively active Akt constructs.

Main Results:

  • Thrombin induced SM-MHC expression (re-differentiation) via biphasic ERK1/2 phosphorylation, with limited Akt activation.
  • PDGF, a mitogen, caused transient ERK1/2 phosphorylation but sustained Akt activation.
  • Akt directly inhibited Raf kinase activity, limiting ERK1/2 phosphorylation; disruption of PI 3-kinase signaling reversed this effect for PDGF.
  • Akt activation blocked thrombin-induced SM-MHC promoter activity, while inhibiting Akt enhanced PDGF-induced SM-MHC activity.

Conclusions:

  • The cross-regulation between PI 3-kinase/Akt and Ras/Raf/MEK pathways is critical for determining the temporal pattern of ERK1/2 phosphorylation.
  • This signaling balance dictates the phenotypic outcome of VSM cells, distinguishing between proliferation and differentiation.
  • Differential activation and cross-talk between these pathways provide a mechanism for controlling VSM cell fate in response to various stimuli.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mechanism of Lamellipodia Formation01:31

Mechanism of Lamellipodia Formation

Cells migrating in response to external stimuli form lamellipodia, which are thin membrane protrusions supported by a mesh of linked, branched, or unbranched actin filaments. These actin filaments interact with myosin motor proteins, creating the dynamic actomyosin complex within the cytoskeleton. Contractility, or the ability to generate contractile stress, is inherent to the actomyosin complex. It helps cells detect the stiffness of the surrounding ECM and exert contractile force for...